Variable |  | Acute CRAO with ILMD (n = 5) | Acute CRAO with no ILMD (n = 23) |
---|---|---|---|
Age (years) |  | 34.8 ± 20.51 | 44.44 ± 20.62 |
Gender (M: F) | Â | 4:1 | 15:8 |
Associated systemic disease | Â | 1 (20) | 13 (57) |
Affected eye (RE: LE) | Â | 3:2 | 11:12 |
Mean duration of symptoms (days) (range) |  | 3.8 (1–7) | 3.78 (1–10) |
Presenting visual acuity |  ≤ 3/60 | 5 (100) | 16 (70) |
 > 3/60 | 0 (0) | 7 (30) | |
OCT features at presentation | Posterior vitreous opacities | 5 (100) | 8 (35) |
Inner retinal thickening | 5 (100) | 13 (57) | |
Inner retinal opacification | 4 (80) | 20 (87) | |
Retinal layer stratification noted | 1 (20) | 8 (35) | |
Cystoid macular edema | 0 (0) | 5 (22) | |
Subretinal fluid | 0 (0) | 5 (22) | |
Final visual acuity |  ≤ 3/60 | 3 (60) | 10 (44) |
 > 3/60 | 0 (0) | 11 (56) | |
OCT features at final visit | Reattachment of ILMD | 1 (20) | Â |
Thinning and atrophy of the inner retinal layers | 3 (60) | 21 (91) | |
Total follow-up duration (mean, range) |  | 23.33 (14–28) | 60.23 (15–210) |